masoprocol has been researched along with Nervous System Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Jiang, J; Kougias, P; Lin, PH; Lü, JM; Nurko, J; Weakley, SM; Yao, Q | 1 |
| Chen, L; Liu, Y; Qu, Y; Wang, H; Zhu, Y | 1 |
1 review(s) available for masoprocol and Nervous System Diseases
| Article | Year |
|---|---|
Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update.
Topics: Animals; Cardiovascular Diseases; Humans; Masoprocol; Nervous System Diseases; Tissue Engineering; Virus Diseases | 2010 |
1 other study(ies) available for masoprocol and Nervous System Diseases
| Article | Year |
|---|---|
The protective effect of nordihydroguaiaretic acid on cerebral ischemia/reperfusion injury is mediated by the JNK pathway.
Topics: Animals; Brain Infarction; Cell Survival; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Embryo, Mammalian; Enzyme Inhibitors; Gene Expression Regulation; Glucose; Hydroxyeicosatetraenoic Acids; Hypoxia; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; MAP Kinase Kinase 4; MAP Kinase Signaling System; Masoprocol; Nervous System Diseases; Neurologic Examination; Neurons; Neuroprotective Agents; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2012 |